KP Tissue Inc. (TSE:KPT – Get Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$11.99 and traded as high as C$12.94. KP Tissue shares last traded at C$12.72, with a volume of 18,947 shares changing hands.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on KPT shares. TD upped their target price on KP Tissue from C$12.00 to C$14.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Desjardins increased their price target on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a research note on Friday, May 15th. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, KP Tissue has a consensus rating of “Hold” and a consensus target price of C$12.12.
Read Our Latest Research Report on KPT
KP Tissue Stock Performance
KP Tissue (TSE:KPT – Get Free Report) last posted its earnings results on Thursday, August 13th. The company reported C$0.24 EPS for the quarter. Equities analysts predict that KP Tissue Inc. will post 0.4398964 earnings per share for the current fiscal year.
KP Tissue Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 15th were issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 6.6%. The ex-dividend date was Tuesday, June 30th. KP Tissue’s payout ratio is currently 85.23%.
Insider Activity
In related news, Director David A. Spraley sold 3,668 shares of the company’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the sale, the director directly owned 15,712 shares of the company’s stock, valued at C$208,969.60. This represents a 18.93% decrease in their position. Insiders have sold a total of 6,668 shares of company stock worth $87,644 over the last 90 days. 0.14% of the stock is currently owned by corporate insiders.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Recommended Stories
- Five stocks we like better than KP Tissue
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
